Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Unraveling virus relationships by structure-based phylogenetic classification.

Ng WM, Stelfox AJ, Bowden TA.

Virus Evol. 2020 Feb 12;6(1):veaa003. doi: 10.1093/ve/veaa003. eCollection 2020 Jan. Review.

2.

A key region of molecular specificity orchestrates unique ephrin-B1 utilization by Cedar virus.

Pryce R, Azarm K, Rissanen I, Harlos K, Bowden TA, Lee B.

Life Sci Alliance. 2019 Dec 20;3(1). pii: e201900578. doi: 10.26508/lsa.201900578. Print 2020 Jan.

3.

Evolutionary Dynamics of Oropouche Virus in South America.

Gutierrez B, Wise EL, Pullan ST, Logue CH, Bowden TA, Escalera-Zamudio M, Trueba G, Nunes MRT, Faria NR, Pybus OG.

J Virol. 2020 Feb 14;94(5). pii: e01127-19. doi: 10.1128/JVI.01127-19. Print 2020 Feb 14.

4.

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus.

Powlson J, Wright D, Zeltina A, Giza M, Nielsen M, Rampling T, Venkatrakaman N, Bowden TA, Hill AVS, Ewer KJ.

Cell Rep. 2019 Nov 26;29(9):2537-2545.e3. doi: 10.1016/j.celrep.2019.10.105.

5.

A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex.

Avanzato VA, Oguntuyo KY, Escalera-Zamudio M, Gutierrez B, Golden M, Kosakovsky Pond SL, Pryce R, Walter TS, Seow J, Doores KJ, Pybus OG, Munster VJ, Lee B, Bowden TA.

Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25057-25067. doi: 10.1073/pnas.1912503116. Epub 2019 Nov 25.

6.

A structure-based rationale for sialic acid independent host-cell entry of Sosuga virus.

Stelfox AJ, Bowden TA.

Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21514-21520. doi: 10.1073/pnas.1906717116. Epub 2019 Oct 7.

7.

Rift Valley fever: biology and epidemiology.

Wright D, Kortekaas J, Bowden TA, Warimwe GM.

J Gen Virol. 2019 Aug;100(8):1187-1199. doi: 10.1099/jgv.0.001296. Epub 2019 Jul 16.

PMID:
31310198
8.

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.

van Doremalen N, Lambe T, Sebastian S, Bushmaker T, Fischer R, Feldmann F, Haddock E, Letko M, Avanzato VA, Rissanen I, LaCasse R, Scott D, Bowden TA, Gilbert S, Munster V.

PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007462. doi: 10.1371/journal.pntd.0007462. eCollection 2019 Jun.

9.

Exploitation of glycosylation in enveloped virus pathobiology.

Watanabe Y, Bowden TA, Wilson IA, Crispin M.

Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1480-1497. doi: 10.1016/j.bbagen.2019.05.012. Epub 2019 May 20. Review.

10.

Author Correction: A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction.

Iliopoulou M, Nolan R, Alvarez L, Watanabe Y, Coomer CA, Jakobsdottir GM, Bowden TA, Padilla-Parra S.

Nat Struct Mol Biol. 2019 Jun;26(6):526. doi: 10.1038/s41594-019-0244-8.

PMID:
31073171
11.

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus.

Allen ER, Krumm SA, Raghwani J, Halldorsson S, Elliott A, Graham VA, Koudriakova E, Harlos K, Wright D, Warimwe GM, Brennan B, Huiskonen JT, Dowall SD, Elliott RM, Pybus OG, Burton DR, Hewson R, Doores KJ, Bowden TA.

Cell Rep. 2018 Dec 26;25(13):3750-3758.e4. doi: 10.1016/j.celrep.2018.12.001.

12.

Structure-Based Classification Defines the Discrete Conformational Classes Adopted by the Arenaviral GP1.

Pryce R, Ng WM, Zeltina A, Watanabe Y, El Omari K, Wagner A, Bowden TA.

J Virol. 2018 Dec 10;93(1). pii: e01048-18. doi: 10.1128/JVI.01048-18. Print 2019 Jan 1.

13.

A naturally protective epitope of limited variability as an influenza vaccine target.

Thompson CP, Lourenço J, Walters AA, Obolski U, Edmans M, Palmer DS, Kooblall K, Carnell GW, O'Connor D, Bowden TA, Pybus OG, Pollard AJ, Temperton NJ, Lambe T, Gilbert SC, Gupta S.

Nat Commun. 2018 Sep 21;9(1):3859. doi: 10.1038/s41467-018-06228-8.

14.

Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in China.

Lu J, Raghwani J, Pryce R, Bowden TA, Thézé J, Huang S, Song Y, Zou L, Liang L, Bai R, Jing Y, Zhou P, Kang M, Yi L, Wu J, Pybus OG, Ke C.

Emerg Infect Dis. 2018 Oct;24(10):1795-1805. doi: 10.3201/eid2410.171063.

15.

A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction.

Iliopoulou M, Nolan R, Alvarez L, Watanabe Y, Coomer CA, Jakobsdottir GM, Bowden TA, Padilla-Parra S.

Nat Struct Mol Biol. 2018 Sep;25(9):814-822. doi: 10.1038/s41594-018-0113-x. Epub 2018 Aug 27. Erratum in: Nat Struct Mol Biol. 2019 Jun;26(6):526.

PMID:
30150645
16.

Structure of the Lassa virus glycan shield provides a model for immunological resistance.

Watanabe Y, Raghwani J, Allen JD, Seabright GE, Li S, Moser F, Huiskonen JT, Strecker T, Bowden TA, Crispin M.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7320-7325. doi: 10.1073/pnas.1803990115. Epub 2018 Jun 25.

17.

Shielding and activation of a viral membrane fusion protein.

Halldorsson S, Li S, Li M, Harlos K, Bowden TA, Huiskonen JT.

Nat Commun. 2018 Jan 24;9(1):349. doi: 10.1038/s41467-017-02789-2.

18.

Genome-wide evolutionary dynamics of influenza B viruses on a global scale.

Langat P, Raghwani J, Dudas G, Bowden TA, Edwards S, Gall A, Bedford T, Rambaut A, Daniels RS, Russell CA, Pybus OG, McCauley J, Kellam P, Watson SJ.

PLoS Pathog. 2017 Dec 28;13(12):e1006749. doi: 10.1371/journal.ppat.1006749. eCollection 2017 Dec.

19.

A10 The evolution and molecular epidemiology of epidemic GII.17 noroviruses.

Lu J, Fang L, Zheng H, Lao J, Yang F, Sun L, Xiao J, Lin J, Song T, Raghwani J, Ke C, Faria NR, Bowden TA, Pybus OG, Li H.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.009. doi: 10.1093/ve/vew036.009. eCollection 2017 Mar. No abstract available.

20.

Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope.

Rissanen I, Stass R, Zeltina A, Li S, Hepojoki J, Harlos K, Gilbert RJC, Huiskonen JT, Bowden TA.

J Virol. 2017 Oct 13;91(21). pii: e00378-17. doi: 10.1128/JVI.00378-17. Print 2017 Nov 1.

21.

Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses.

Rissanen I, Ahmed AA, Azarm K, Beaty S, Hong P, Nambulli S, Duprex WP, Lee B, Bowden TA.

Nat Commun. 2017 Jul 12;8:16060. doi: 10.1038/ncomms16060.

22.

Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.

Zeltina A, Bowden TA.

Nat Struct Mol Biol. 2017 Jul 6;24(7):559-560. doi: 10.1038/nsmb.3431. No abstract available.

PMID:
28686227
23.

Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.

Zeltina A, Krumm SA, Sahin M, Struwe WB, Harlos K, Nunberg JH, Crispin M, Pinschewer DD, Doores KJ, Bowden TA.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7031-7036. doi: 10.1073/pnas.1702127114. Epub 2017 Jun 19.

24.

Effect of Live Poultry Market Interventions on Influenza A(H7N9) Virus, Guangdong, China.

Wu J, Lu J, Faria NR, Zeng X, Song Y, Zou L, Yi L, Liang L, Ni H, Kang M, Zhang X, Huang G, Zhong H, Bowden TA, Raghwani J, He J, He X, Lin J, Koopmans M, Pybus OG, Ke C.

Emerg Infect Dis. 2016 Dec;22(12):2104-2112. doi: 10.3201/eid2212.160450.

25.

Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats.

Beaty SM, Nachbagauer R, Hirsh A, Vigant F, Duehr J, Azarm KD, Stelfox AJ, Bowden TA, Duprex WP, Krammer F, Lee B.

J Infect Dis. 2017 Jan 15;215(2):209-213. doi: 10.1093/infdis/jiw534.

26.

Toremifene interacts with and destabilizes the Ebola virus glycoprotein.

Zhao Y, Ren J, Harlos K, Jones DM, Zeltina A, Bowden TA, Padilla-Parra S, Fry EE, Stuart DI.

Nature. 2016 Jul 7;535(7610):169-172. doi: 10.1038/nature18615. Epub 2016 Jun 29.

27.

A Molecular-Level Account of the Antigenic Hantaviral Surface.

Li S, Rissanen I, Zeltina A, Hepojoki J, Raghwani J, Harlos K, Pybus OG, Huiskonen JT, Bowden TA.

Cell Rep. 2016 Jun 28;16(1):278. doi: 10.1016/j.celrep.2016.06.039. Epub 2016 Jun 28. No abstract available.

28.

The Evolution and Transmission of Epidemic GII.17 Noroviruses.

Lu J, Fang L, Zheng H, Lao J, Yang F, Sun L, Xiao J, Lin J, Song T, Ni T, Raghwani J, Ke C, Faria NR, Bowden TA, Pybus OG, Li H.

J Infect Dis. 2016 Aug 15;214(4):556-64. doi: 10.1093/infdis/jiw208. Epub 2016 May 24.

29.

Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.

Halldorsson S, Behrens AJ, Harlos K, Huiskonen JT, Elliott RM, Crispin M, Brennan B, Bowden TA.

Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7154-9. doi: 10.1073/pnas.1603827113. Epub 2016 Jun 20.

30.

A Molecular-Level Account of the Antigenic Hantaviral Surface.

Li S, Rissanen I, Zeltina A, Hepojoki J, Raghwani J, Harlos K, Pybus OG, Huiskonen JT, Bowden TA.

Cell Rep. 2016 May 3;15(5):959-967. doi: 10.1016/j.celrep.2016.03.082. Epub 2016 Apr 21. Erratum in: Cell Rep. 2016 Jun 28;16(1):278.

31.

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies.

Le NP, Bowden TA, Struwe WB, Crispin M.

Biochim Biophys Acta. 2016 Aug;1860(8):1655-68. doi: 10.1016/j.bbagen.2016.04.016. Epub 2016 Apr 20. Review.

32.

Native functionality and therapeutic targeting of arenaviral glycoproteins.

Crispin M, Zeltina A, Zitzmann N, Bowden TA.

Curr Opin Virol. 2016 Jun;18:70-5. doi: 10.1016/j.coviro.2016.04.001. Epub 2016 Apr 19. Review.

33.

Zika virus in the Americas: Early epidemiological and genetic findings.

Faria NR, Azevedo RDSDS, Kraemer MUG, Souza R, Cunha MS, Hill SC, Thézé J, Bonsall MB, Bowden TA, Rissanen I, Rocco IM, Nogueira JS, Maeda AY, Vasami FGDS, Macedo FLL, Suzuki A, Rodrigues SG, Cruz ACR, Nunes BT, Medeiros DBA, Rodrigues DSG, Queiroz ALN, da Silva EVP, Henriques DF, da Rosa EST, de Oliveira CS, Martins LC, Vasconcelos HB, Casseb LMN, Simith DB, Messina JP, Abade L, Lourenço J, Alcantara LCJ, de Lima MM, Giovanetti M, Hay SI, de Oliveira RS, Lemos PDS, de Oliveira LF, de Lima CPS, da Silva SP, de Vasconcelos JM, Franco L, Cardoso JF, Vianez-Júnior JLDSG, Mir D, Bello G, Delatorre E, Khan K, Creatore M, Coelho GE, de Oliveira WK, Tesh R, Pybus OG, Nunes MRT, Vasconcelos PFC.

Science. 2016 Apr 15;352(6283):345-349. doi: 10.1126/science.aaf5036. Epub 2016 Mar 24.

34.

Emerging Paramyxoviruses: Receptor Tropism and Zoonotic Potential.

Zeltina A, Bowden TA, Lee B.

PLoS Pathog. 2016 Feb 25;12(2):e1005390. doi: 10.1371/journal.ppat.1005390. eCollection 2016 Feb. No abstract available.

35.

Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.

Li S, Sun Z, Pryce R, Parsy ML, Fehling SK, Schlie K, Siebert CA, Garten W, Bowden TA, Strecker T, Huiskonen JT.

PLoS Pathog. 2016 Feb 5;12(2):e1005418. doi: 10.1371/journal.ppat.1005418. eCollection 2016 Feb.

36.

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.

Dowall SD, Callan J, Zeltina A, Al-Abdulla I, Strecker T, Fehling SK, Krähling V, Bosworth A, Rayner E, Taylor I, Charlton S, Landon J, Cameron I, Hewson R, Nasidi A, Bowden TA, Carroll MW.

J Infect Dis. 2016 Apr 1;213(7):1124-33. doi: 10.1093/infdis/jiv565. Epub 2015 Dec 28.

37.

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

Sommerstein R, Flatz L, Remy MM, Malinge P, Magistrelli G, Fischer N, Sahin M, Bergthaler A, Igonet S, Ter Meulen J, Rigo D, Meda P, Rabah N, Coutard B, Bowden TA, Lambert PH, Siegrist CA, Pinschewer DD.

PLoS Pathog. 2015 Nov 20;11(11):e1005276. doi: 10.1371/journal.ppat.1005276. eCollection 2015 Nov.

38.

Determination of N-linked Glycosylation in Viral Glycoproteins by Negative Ion Mass Spectrometry and Ion Mobility.

Bitto D, Harvey DJ, Halldorsson S, Doores KJ, Pritchard LK, Huiskonen JT, Bowden TA, Crispin M.

Methods Mol Biol. 2015;1331:93-121. doi: 10.1007/978-1-4939-2874-3_7.

39.

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Pritchard LK, Spencer DI, Royle L, Bonomelli C, Seabright GE, Behrens AJ, Kulp DW, Menis S, Krumm SA, Dunlop DC, Crispin DJ, Bowden TA, Scanlan CN, Ward AB, Schief WR, Doores KJ, Crispin M.

Nat Commun. 2015 Jun 24;6:7479. doi: 10.1038/ncomms8479.

40.

Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.

Lee B, Pernet O, Ahmed AA, Zeltina A, Beaty SM, Bowden TA.

Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2156-65. doi: 10.1073/pnas.1501690112. Epub 2015 Mar 30.

41.

Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.

Garner OB, Yun T, Pernet O, Aguilar HC, Park A, Bowden TA, Freiberg AN, Lee B, Baum LG.

J Virol. 2015 Mar;89(5):2520-9. doi: 10.1128/JVI.02435-14. Epub 2014 Dec 10.

42.

Evidence for henipavirus spillover into human populations in Africa.

Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, Zachariah TT, Bowden TA, Hitchens P, Ramirez CM, Daszak P, Mazet J, Freiberg AN, Wolfe ND, Lee B.

Nat Commun. 2014 Nov 18;5:5342. doi: 10.1038/ncomms6342.

43.

Averaging of viral envelope glycoprotein spikes from electron cryotomography reconstructions using Jsubtomo.

Huiskonen JT, Parsy ML, Li S, Bitto D, Renner M, Bowden TA.

J Vis Exp. 2014 Oct 21;(92):e51714. doi: 10.3791/51714.

44.

Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome.

Crispin M, Harvey DJ, Bitto D, Halldorsson S, Bonomelli C, Edgeworth M, Scrivens JH, Huiskonen JT, Bowden TA.

J Virol. 2014 Sep 1;88(17):10244-51. doi: 10.1128/JVI.01662-14. Epub 2014 Jun 18.

45.

Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.

Crispin M, Harvey DJ, Bitto D, Bonomelli C, Edgeworth M, Scrivens JH, Huiskonen JT, Bowden TA.

J Proteome Res. 2014 Mar 7;13(3):1702-12. doi: 10.1021/pr401162k. Epub 2014 Feb 10.

46.

Crystal structure of Venezuelan hemorrhagic fever virus fusion glycoprotein reveals a class 1 postfusion architecture with extensive glycosylation.

Parsy ML, Harlos K, Huiskonen JT, Bowden TA.

J Virol. 2013 Dec;87(23):13070-5. doi: 10.1128/JVI.02298-13. Epub 2013 Sep 18.

47.

Antibodies expose multiple weaknesses in the glycan shield of HIV.

Crispin M, Bowden TA.

Nat Struct Mol Biol. 2013 Jul;20(7):771-2.

PMID:
23984441
48.

Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.

Crispin M, Yu X, Bowden TA.

Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3544-6. doi: 10.1073/pnas.1310657110. Epub 2013 Aug 8. No abstract available.

49.

Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies.

Yu X, Baruah K, Harvey DJ, Vasiljevic S, Alonzi DS, Song BD, Higgins MK, Bowden TA, Scanlan CN, Crispin M.

J Am Chem Soc. 2013 Jul 3;135(26):9723-32. doi: 10.1021/ja4014375. Epub 2013 Jun 25.

50.

Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike.

Bowden TA, Bitto D, McLees A, Yeromonahos C, Elliott RM, Huiskonen JT.

PLoS Pathog. 2013;9(5):e1003374. doi: 10.1371/journal.ppat.1003374. Epub 2013 May 16.

Supplemental Content

Loading ...
Support Center